Engraftment potential of human amnion and chorion cells derived from term placenta
- PMID: 15599307
- DOI: 10.1097/01.tp.0000144606.84234.49
Engraftment potential of human amnion and chorion cells derived from term placenta
Abstract
Background: Fetal membranes are tissues of particular interest for several reasons, including their role in preventing rejection of the fetus and their early embryologic origin. which may entail progenitor potential. The immunologic reactivity and the transplantation potential of amnion and chorion cells, however, remain to be elucidated.
Methods: Amnion and chorion cells were isolated from human term placenta and characterized by immunohistochemistry, flow cytometric analysis, and expression profile of relevant genes. The immunomodulatory characteristics of these cells were studied in allogeneic and xenogeneic mixed lymphocyte reactions and their engraftment potential analyzed by transplantation into neonatal swine and rats. Posttransplant chimerism was determined by polymerase chain reaction analysis with probes specific for human DNA.
Results: Phenotypic and gene expression studies indicated mesenchymal stem cell-like profiles in both amnion and chorion cells that were positive for neuronal, pulmonary, adhesion, and migration markers. In addition, cells isolated both from amnion and chorion did not induce allogeneic nor xenogeneic lymphocyte proliferation responses and were able to actively suppress lymphocyte responsiveness. Transplantation in neonatal swine and rats resulted in human microchimerism in various organs and tissues.
Conclusions: Human amnion and chorion cells from term placenta can successfully engraft neonatal swine and rats. These results may be explained by the peculiar immunologic characteristics and mesenchymal stem cell-like phenotype of these cells. These findings suggest that amnion and chorion cells may represent an advantageous source of progenitor cells with potential applications in a variety of cell therapy and transplantation procedures.
Comment in
-
Amnion and chorion cells as therapeutic agents for transplantation and tissue regeneration: a field in its infancy.Transplantation. 2004 Nov 27;78(10):1411-2. doi: 10.1097/01.tp.0000144056.92919.54. Transplantation. 2004. PMID: 15599302 No abstract available.
Similar articles
-
Isolation and basic characterization of human term amnion and chorion mesenchymal stromal cells.Cytotherapy. 2011 Oct;13(9):1047-56. doi: 10.3109/14653249.2011.592522. Cytotherapy. 2011. PMID: 21916779
-
Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis.Cell Transplant. 2009;18(4):405-22. doi: 10.3727/096368909788809857. Cell Transplant. 2009. PMID: 19622228
-
Hematogenous Donor Cell Routing Pathway After Transamniotic Stem Cell Therapy.Stem Cells Dev. 2020 Jun 15;29(12):755-760. doi: 10.1089/scd.2020.0012. Epub 2020 Apr 29. Stem Cells Dev. 2020. PMID: 32228172
-
Fetal membranes as a source of stem cells.Adv Med Sci. 2013;58(2):185-95. doi: 10.2478/ams-2013-0007. Adv Med Sci. 2013. PMID: 24327530 Review.
-
Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells.Stem Cells. 2008 Feb;26(2):300-11. doi: 10.1634/stemcells.2007-0594. Epub 2007 Nov 1. Stem Cells. 2008. PMID: 17975221 Review.
Cited by
-
A Novel Dehydrated Human Umbilical Cord Particulate Medical Device: Matrix Characterization, Performance, and Biocompatibility for the Management of Acute and Chronic Wounds.Bioengineering (Basel). 2024 Jun 8;11(6):588. doi: 10.3390/bioengineering11060588. Bioengineering (Basel). 2024. PMID: 38927824 Free PMC article.
-
Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model.Oncol Lett. 2012 Sep;4(3):413-418. doi: 10.3892/ol.2012.772. Epub 2012 Jun 22. Oncol Lett. 2012. PMID: 23741242 Free PMC article.
-
Transplantation of human placental chorionic plate-derived mesenchymal stem cells for repair of neurological damage in neonatal hypoxic-ischemic encephalopathy.Neural Regen Res. 2024 Sep 1;19(9):2027-2035. doi: 10.4103/1673-5374.390952. Epub 2023 Dec 15. Neural Regen Res. 2024. PMID: 38227532 Free PMC article.
-
Phase 1 Trial of Amnion Cell Therapy for Ischemic Stroke.Front Neurol. 2018 Jun 7;9:198. doi: 10.3389/fneur.2018.00198. eCollection 2018. Front Neurol. 2018. PMID: 29930530 Free PMC article.
-
Stem cell therapy to protect and repair the developing brain: a review of mechanisms of action of cord blood and amnion epithelial derived cells.Front Neurosci. 2013 Oct 24;7:194. doi: 10.3389/fnins.2013.00194. Front Neurosci. 2013. PMID: 24167471 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources